by Truveta staff | Mar 20, 2025 | Data
Why autoimmune research needs better real-world data Biologics like Humira, Enbrel, and Rinvoq have transformed autoimmune treatment, revolutionizing treatment for patients with chronic inflammatory infections. However, the traditional methods of studying these...
by Truveta staff | Jan 21, 2025 | Research
Overall, the rate of hospitalizations associated with respiratory viruses increased 3-fold between the end of November and end of December (209.2% increase). Respiratory viruses now are associated with 9.3% of all hospitalizations. Rates of influenza-associated...
by Truveta staff | Jan 9, 2025 | Data
In the world of medical research, data drives discovery. But until recently, nearly 80% of data relevant to research has been hidden in clinical notes. These notes include detailed observations, symptoms, and treatment plans that are absent from the structured data...
by Jay Nanduri | Dec 10, 2024 | Technology
In the final article in this series, I will share some thoughts on meeting the following challenge: How to rapidly support new AI scenarios and adjacencies through reuse and transfer learning? Truveta has diverse, multimodal, and up-to-date data on clinical...
by Truveta staff | Oct 10, 2024 | Data
The US market size for joint replacement is projected to balloon to nearly $38 billion by 2030, nearly doubling its 2022 value. The combination of an aging population, increasing rates of osteoarthritis and obesity, along with advancing technology, are all...
